Results 11 to 20 of about 31,255 (186)

COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. [PDF]

Surg Endosc, 2016
Total mesorectal excision (TME) is an essential component of surgical management of rectal cancer. Both open and laparoscopic TME have been proven to be oncologically safe. However, it remains a challenge to achieve complete TME with clear circumferential resections margin (CRM) with the conventional transabdominal approach, particularly in mid and low
Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, Sietses C, Tuynman JB, Lacy AM, Hanna GB, Bonjer HJ.   +9 more
europepmc   +9 more sources

Hybrid transanal and total mesorectal excision after transanal endoscopic microsurgery for unfavourable early rectal cancer: a report of two cases [PDF]

Acta Medica Lituanica, 2017
Completion total mesorectal excision (TME) is a rare but complex procedure after transanal endoscopic microsurgery for early rectal cancer with unfavourable final histology.
Narimantas E. Samalavičius, Audrius Dulskas, Kęstutis Petrulis, Alfredas Kilius, Renatas Tikuišis, Raimundas Lunevičius   +5 more
doaj   +2 more sources

Pure natural orifice transluminal endoscopic surgery for rectal cancer: Ta-TME and CME without abdominal assistance

Asian Journal of Surgery, 2019
Summary: Aim: To report our institution's experiences with pure transanal total mesorectal excision (TME) of rectal cancer using single-port equipment and to discuss the feasibility and safety of the technique.
Won Jun Jeong, Byung Jo Choi, Sang Chul Lee   +2 more
doaj   +2 more sources

Transanal Total Mesorectal Excision (TaTME): A Literature Review [PDF]

Journal of Biomedical & Clinical Research, 2020
Total mesorectal excision (TME) has become the golden standard for treating rectal cancer since Heald introduced it [1]. Transanal total mesorectal excision (taTME) is an innovative surgical method for rectal cancer.
Martin Karamanliev, Dobromir Dimitrov
doaj   +4 more sources

Comparison of Transanal Endoscopic Microsurgery and Total Mesorectal Excision in the Treatment of T1 Rectal Cancer: A Meta-Analysis. [PDF]

PLoS ONE, 2015
Transanal endoscopic microsurgery (TEM) for the treatment of early-stage rectal cancer has attracted attention due to its advantages of reduced surgical trauma, fewer complications, low operative mortality, rapid postoperative recovery and short hospital
Jun-Yang Lu, Guo-Le Lin, Hui-Zhong Qiu, Yi Xiao, Bin Wu, Jiao-Lin Zhou   +5 more
doaj   +2 more sources

Combined laparoscopic and transanal total mesorectal excision for rectal cancer: Initial experience and early results

Journal of Minimal Access Surgery, 2017
Introduction: Incomplete specimens resulting in residual mesorectum in the patient and an increased risk of local recurrence remains a problem. We have introduced transanal-total mesorectal excision (Ta-TME) in our department to potentially overcome this
Morten Holt Thomsen, Henrik Ovesen, Jens Ravn Eriksen   +2 more
doaj   +2 more sources

Transanal total mesorectal excision for low rectal cancer: a case-matched study comparing TaTME versus standard laparoscopic TME

Cancer Management and Research, 2018
Mateusz Rubinkiewicz,1 Michał Nowakowski,2 Mateusz Wierdak,1,3 Magdalena Mizera,1 Marcin Dembiński,1 Magdalena Pisarska,1,3 Piotr Major,1,3 Piotr Małczak,1,3 Andrzej Budzyński,1,3 Michał Pędziwiatr1,3 12nd Department of General Surgery, Jagiellonian ...
Rubinkiewicz M, Nowakowski M, Wierdak M, Mizera M, Dembiński M, Pisarska M, Major P, Małczak P, Budzyński A, Pędziwiatr M   +9 more
doaj   +1 more source

A Rare Finding of Retroperitoneal Sepsis Following Robot-Assisted Transanal Minimally Invasive Surgery (TAMIS): A Case Report and Review of the Literature. [PDF]

Clin Case Rep
ABSTRACT Robot‐assisted transanal minimally invasive surgery (TAMIS) is a safe and effective platform for the local excision of early rectal lesions. While postoperative complications such as bleeding or contained perforation are recognized, rapidly progressive retroperitoneal sepsis remains an exceedingly rare occurrence.
Tiong J, Le KDR, Wang AJ, Flanagan J, Udayasiri D.   +4 more
europepmc   +2 more sources

Indocyanine green-guided robotic-assisted mesorectal lymphadenectomy for high-risk T1 rectal carcinoma: Preliminary results of a prospective cohort study (IDEAL stage 2a). [PDF]

Colorectal Dis
Abstract Aim Lymph node metastases occur in 10%–15% of high‐risk T1 rectal tumours. Total mesorectal excision remains the standard treatment, whereas chemoradiotherapy is reserved for patients with frailty. Indocyanine green (ICG)‐guided lymphadenectomy may represent an organ‐preserving alternative for patients at high risk of node metastasis.
Rouanet P, Flori N, Bouazza N, Houmada A, Khellaf L, Taoum C.   +5 more
europepmc   +2 more sources

Robotic, transanal, and laparoscopic total mesorectal excision for locally advanced mid/low rectal cancer: European multicentre, propensity score-matched study [PDF]

Background: Total mesorectal excision (TME) is the standard surgery for low/mid locally advanced rectal cancer. The aim of this study was to compare three minimally invasive surgical approaches for TME with primary anastomosis (laparoscopic TME, robotic ...
Persiani, Roberto, null, null, Morelli, Luca, Tuynman, Jurriaan B, Pucciarelli, Salvatore, Kraft, Miquel, Espin-Basany, Eloy, Torres-Sánchez, Teresa, Martínez-Pérez, Aleix, Valverde, Alain, de'Angelis, Nicola, Schena, Carlo Alberto, Biondi, Alberto, Marchegiani, Francesco, Ris, Frederic, Spolverato, Gaya, Martí-Martínez, Eva, Gómez-Abril, Segundo A, Bianchi, Giorgio, Pellino, Gianluca, Guadagni, Simone, Maretto, Isacco, Solis, Alejandro, Lupinacci, Renato Micelli, Sebastián-Tomás, Juan Carlos, van Lieshout, Annabel S   +25 more
core   +7 more sources